{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:38:20Z","timestamp":1783003100814,"version":"3.54.5"},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bulcan.2023.08.002","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T08:03:49Z","timestamp":1696579429000},"page":"97-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic des sarcomes ut\u00e9rins et tumeurs m\u00e9senchymateuses ut\u00e9rines rares \u00e0 potentiel de malignit\u00e9. R\u00e9f\u00e9rentiels du Groupe Sarcome Fran\u00e7ais et des Tumeurs Rares Gyn\u00e9cologiques"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6487-5418","authenticated-orcid":false,"given":"Sabrina","family":"Croce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Devouassoux-Shisheboran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ray-Coquard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Treilleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Neuville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Arnould","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Alexandre","family":"Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Aude","family":"Le frere Belda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerlinde","family":"Averous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bataillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Mery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Loussouarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Weinbreck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Le Guellec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Mishellany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Morice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Guyon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Genestie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bulcan.2023.08.002_bib0460","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41379-020-00705-6","article-title":"Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma","volume":"34","author":"Momeni-Boroujeni","year":"2021","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.08.002_bib0465","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/PAS.0000000000001572","article-title":"Genomic profiling aids classification of diagnostically challenging uterine mesenchymal tumors with myomelanocytic differentiation","volume":"45","author":"Selenica","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.08.002_bib0470","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2020.08.008","article-title":"State of the science: uterine sarcomas: from pathology to practice","volume":"159","author":"Shushkevich","year":"2020","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.08.002_bib0475","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ygyno.2003.12.029","article-title":"Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989\u20131999","volume":"93","author":"Brooks","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.bulcan.2023.08.002_bib0480","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1002\/ijc.22239","article-title":"Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978\u20132001: an analysis of 26,758 cases","volume":"119","author":"Toro","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0485","series-title":"Female genital tumours","article-title":"Smooth muscle tumour of uncertain malignant potential","author":"Ip","year":"2020"},{"issue":"4","key":"10.1016\/j.bulcan.2023.08.002_bib0490","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/PAS.0000000000001795","article-title":"Epithelioid leiomyosarcoma of the uterus: modern outcome-based appraisal of diagnostic criteria in a large institutional series","volume":"46","author":"Chapel","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.bulcan.2023.08.002_bib0495","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/modpathol.2015.3","article-title":"Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions","volume":"28","author":"Croce","year":"2015","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.bulcan.2023.08.002_bib0500","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/modpathol.2017.185","article-title":"Genome profiling is an efficient tool to avoid the STUMP classification of uterine smooth muscle lesions: a comprehensive array-genomic hybridization analysis of 77 tumors","volume":"31","author":"Croce","year":"2018","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.002_bib0505","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1245\/s10434-022-12697-5","article-title":"Percutaneous uterine needle biopsy with microscopic and array-CGH analyses for preoperative sarcoma diagnosis in patients with suspicious myometrial tumors on MRI: a prospective pilot study (SARCGYN)","volume":"30","author":"Smadja","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0510","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/gcc.22906","article-title":"Molecular prognostication of uterine smooth muscle neoplasms: from CGH array to CINSARC signature and beyond","volume":"60","author":"Croce","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0515","series-title":"Female genital tumours","article-title":"Uterine leiomyosarcoma","author":"Longacre","year":"2020"},{"issue":"4","key":"10.1016\/j.bulcan.2023.08.002_bib0535","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1158\/1078-0432.CCR-19-2891","article-title":"The nanocind signature is an independent prognosticator of recurrence and death in uterine leiomyosarcomas","volume":"26","author":"Croce","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.bulcan.2023.08.002_bib0520","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/(SICI)1097-0142(20000315)88:6<1425::AID-CNCR21>3.0.CO;2-3","article-title":"Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma","volume":"88","author":"Pautier","year":"2000","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.bulcan.2023.08.002_bib0525","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/PAS.0000000000001795","article-title":"Epithelioid leiomyosarcoma of the uterus: modern outcome-based appraisal of diagnostic criteria in a large institutional series","volume":"46","author":"Chapel","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0530","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/gcc.22920","article-title":"Recent advances in smooth muscle tumors with PGR and PLAG1 gene fusions and myofibroblastic uterine neoplasms","volume":"60","author":"Chiang","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0540","series-title":"Female genital tumors","article-title":"Low-grade endometrial stromal sarcoma","author":"Lee","year":"2020"},{"issue":"4","key":"10.1016\/j.bulcan.2023.08.002_bib0545","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/PGP.0000000000000424","article-title":"IFITM1 outperforms CD10 in differentiating low-grade endometrial stromal sarcomas from smooth muscle neoplasms of the uterus","volume":"37","author":"Busca","year":"2018","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"10.1016\/j.bulcan.2023.08.002_bib0550","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/PGP.0000000000000730","article-title":"SATB2 expression in uterine sarcoma: a multicenter retrospective study","volume":"40","author":"Le Page","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0555","series-title":"Female genital tumours","article-title":"High-grade endometrial stromal sarcoma","author":"Chiang","year":"2020"},{"issue":"5","key":"10.1016\/j.bulcan.2023.08.002_bib0560","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/PAS.0b013e31824a7b1a","article-title":"The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0565","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1073\/pnas.1115528109","article-title":"14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma","volume":"109","author":"Lee","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0570","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/PAS.0000000000000993","article-title":"BCOR internal tandem duplication in high-grade uterine sarcomas","volume":"42","author":"Marino-Enriquez","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.bulcan.2023.08.002_bib0575","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.3390\/cancers12092604","article-title":"Molecular classification of endometrial stromal sarcomas using RNA sequencing defines nosological and prognostic subgroups with different natural history","volume":"12","author":"Brahmi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.bulcan.2023.08.002_bib0580","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/modpathol.2013.69","article-title":"YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations","volume":"26","author":"Croce","year":"2013","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.08.002_bib0585","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PAS.0000000000000721","article-title":"Novel high-grade endometrial stromal sarcoma: a morphologic mimicker of myxoid leiomyosarcoma","volume":"41","author":"Hoang","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.002_bib0590","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pathol.2017.11.086","article-title":"Endometrial stromal sarcomas and related neoplasms: new developments and diagnostic considerations","volume":"50","author":"Hoang","year":"2018","journal-title":"Pathology"},{"issue":"10","key":"10.1016\/j.bulcan.2023.08.002_bib0595","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/PAS.0b013e31825fa931","article-title":"Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement","volume":"36","author":"Lee","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.bulcan.2023.08.002_bib0600","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2013.199","article-title":"Frequent expression of KIT in endometrial stromal sarcoma with YWHAE genetic rearrangement","volume":"27","author":"Lee","year":"2014","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.bulcan.2023.08.002_bib0605","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/modpathol.2017.42","article-title":"BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology","volume":"30","author":"Chiang","year":"2017","journal-title":"Mod Pathol"},{"issue":"4","key":"10.1016\/j.bulcan.2023.08.002_bib0610","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/modpathol.2017.162","article-title":"ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity","volume":"31","author":"Lewis","year":"2018","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0615","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/cjp2.165","article-title":"Endometrial stromal sarcomas with BCOR-rearrangement harbor MDM2 amplifications","volume":"6","author":"Kommoss","year":"2020","journal-title":"J Pathol Clin Res"},{"issue":"8","key":"10.1016\/j.bulcan.2023.08.002_bib0620","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/PAS.0000000000001909","article-title":"Endometrial stromal sarcomas with BCOR internal tandem duplication and variant BCOR\/BCORL1 rearrangements resemble high-grade endometrial stromal sarcomas with recurrent CDK4 pathway alterations and MDM2 amplifications","volume":"46","author":"Kommoss","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.bulcan.2023.08.002_bib0625","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/PGP.0000000000000187","article-title":"Analysis of MDM2 amplification in 43 endometrial stromal tumors: a potential diagnostic pitfall","volume":"34","author":"Schoolmeester","year":"2015","journal-title":"Int J Gynecol Pathol"},{"issue":"9","key":"10.1016\/j.bulcan.2023.08.002_bib0630","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/PAS.0000000000000256","article-title":"High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features","volume":"38","author":"Sciallis","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.bulcan.2023.08.002_bib0635","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1038\/s41379-020-0535-y","article-title":"High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities","volume":"33","author":"Zou","year":"2020","journal-title":"Mod Pathol"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0640","series-title":"Female genital tumours","article-title":"Undifferentiated uterine sarcoma","author":"Chiang Sarah","year":"2020"},{"issue":"8","key":"10.1016\/j.bulcan.2023.08.002_bib0645","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/PAS.0b013e31816a3b42","article-title":"Endometrial stromal sarcomas and related high-grade sarcomas: immunohistochemical and molecular genetic study of 31 cases","volume":"32","author":"Kurihara","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.bulcan.2023.08.002_bib0650","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/PAS.0000000000001215","article-title":"Undifferentiated uterine sarcomas represent under-recognized high-grade endometrial stromal sarcomas","volume":"43","author":"Cotzia","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0655","series-title":"Female genital tumours","article-title":"Adenosarcoma of uterine corpus","author":"Howitt Brooke","year":"2020"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.002_bib0660","first-page":"93","article-title":"The Eighth Edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"10.1016\/j.bulcan.2023.08.002_bib0665","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/PAS.0000000000000907","article-title":"High-grade Mullerian adenosarcoma: genomic and clinicopathologic characterization of a distinct neoplasm with prevalent TP53 pathway alterations and aggressive behavior","volume":"41","author":"Hodgson","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0670","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/gcc.22913","article-title":"DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: pathology, molecular genetics, and indications for molecular testing","volume":"60","author":"Apellaniz-Ruiz","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.002_bib0675","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41379-018-0132-5","article-title":"DICER1 mutations are frequent in mullerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation","volume":"32","author":"Bean","year":"2019","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.bulcan.2023.08.002_bib0680","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41379-022-01160-1","article-title":"Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors","volume":"35","author":"Momeni-Boroujeni","year":"2022","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.08.002_bib0685","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13000-022-01279-4","article-title":"Differential diagnosis of uterine adenosarcoma: identification of JAZF1-BCORL1 rearrangement by comprehensive cancer genomic profiling","volume":"18","author":"Hasegawa","year":"2023","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0690","series-title":"Female genital tumours","article-title":"Perivascular epithelioid cell tumour (PEComa)","author":"Bennett Jennifer","year":"2020"},{"issue":"10","key":"10.1016\/j.bulcan.2023.08.002_bib0695","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/PAS.0000000000001119","article-title":"Uterine PEComas: a morphologic, immunohistochemical, and molecular analysis of 32 tumors","volume":"42","author":"Bennett","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"54","key":"10.1016\/j.bulcan.2023.08.002_bib0700","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1038\/sj.onc.1204009","article-title":"The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination","volume":"19","author":"Benvenuto","year":"2000","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0705","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1158\/0008-5472.CAN-06-2855","article-title":"TFE3 fusions activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition","volume":"67","author":"Tsuda","year":"2007","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.bulcan.2023.08.002_bib0710","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.3390\/cancers13205227","article-title":"Natural history and treatment strategies of advanced PEComas: a systematic review","volume":"13","author":"Bourgmayer","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.bulcan.2023.08.002_bib0715","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41379-021-00855-1","article-title":"Uterine PEComas: correlation between melanocytic marker expression and TSC alterations\/TFE3 fusions","volume":"35","author":"Bennett","year":"2021","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0720","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/gcc.22922","article-title":"Update on SWI\/SNF-related gynecologic mesenchymal neoplasms: SMARCA4-deficient uterine sarcoma and SMARCB1-deficient vulvar neoplasms","volume":"60","author":"Howitt","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.002_bib0725","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/PAS.0000000000001375","article-title":"SMARCA4-deficient uterine sarcoma and undifferentiated endometrial carcinoma are distinct clinicopathologic entities","volume":"44","author":"Kolin","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0730","series-title":"Female genital tumours","article-title":"Rhabdomyosarcoma","author":"Barr Frederic","year":"2020"},{"issue":"4","key":"10.1016\/j.bulcan.2023.08.002_bib0735","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/modpathol.2011.185","article-title":"Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations","volume":"25","author":"Dehner","year":"2012","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0740","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/PAS.0b013e31826e0271","article-title":"Embryonal rhabdomyosarcoma (botryoid type) of the uterine corpus and cervix in adult women: report of a case series and review of the literature","volume":"37","author":"Li","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0745","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.pas.0000213352.87885.75","article-title":"Clinicopathologic features of rhabdomyosarcoma of gynecologic origin in adults","volume":"31","author":"Ferguson","year":"2007","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.bulcan.2023.08.002_bib0750","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41379-019-0436-0","article-title":"Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma","volume":"33","author":"de Kock","year":"2020","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.bulcan.2023.08.002_bib0755","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/s41379-021-00804-y","article-title":"Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup","volume":"34","author":"Kommoss","year":"2021","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.bulcan.2023.08.002_bib0760","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1038\/s41379-021-00821-x","article-title":"Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations","volume":"34","author":"Bennett","year":"2021","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.bulcan.2023.08.002_bib0765","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/humu.23877","article-title":"Ten years of DICER1 mutations: provenance, distribution, and associated phenotypes","volume":"40","author":"de Kock","year":"2019","journal-title":"Hum Mutat"},{"issue":"7","key":"10.1016\/j.bulcan.2023.08.002_bib0770","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41379-018-0184-6","article-title":"Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms","volume":"32","author":"Croce","year":"2019","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0775","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/gcc.22910","article-title":"NTRK and other recently described kinase fusion positive uterine sarcomas: a review of a group of rare neoplasms","volume":"60","author":"Croce","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0780","doi-asserted-by":"crossref","first-page":"100845","DOI":"10.1016\/j.gore.2021.100845","article-title":"Case report: NTRK1-rearranged cervical sarcoma with fibrosarcoma like morphology presenting in a 13-year-old managed with a neo-adjuvant TRK-inhibitor and surgical excision","volume":"37","author":"Goulding","year":"2021","journal-title":"Gynecol Oncol Rep"},{"issue":"6","key":"10.1016\/j.bulcan.2023.08.002_bib0785","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/PAS.0000000000001055","article-title":"NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma","volume":"42","author":"Chiang","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.08.002_bib0790","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/his.14069","article-title":"NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma","volume":"77","author":"Rabban","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0795","doi-asserted-by":"crossref","first-page":"100653","DOI":"10.1016\/j.gore.2020.100653","article-title":"COL1A1-PDGFB fusion uterine sarcoma and its response to imatinib therapy","volume":"34","author":"Grindstaff","year":"2020","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0800","series-title":"Female genital tumours","article-title":"Uterine tumour resembling ovarian sex cord tumour","author":"Staat","year":"2020"},{"issue":"5","key":"10.1016\/j.bulcan.2023.08.002_bib0805","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/his.13296","article-title":"Uterine tumour resembling ovarian sex cord tumour (UTROSCT): first report of a large series with follow-up","volume":"71","author":"Moore","year":"2017","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0810","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ajcp\/66.3.512","article-title":"Uterine tumors resembling ovarian sex-cord tumors. A clinicopathologic analysis of fourteen cases","volume":"66","author":"Clement","year":"1976","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.bulcan.2023.08.002_bib0815","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1097\/PAS.0000000000001265","article-title":"Clinicopathologic characterization of GREB1-rearranged uterine sarcomas with variable sex-cord differentiation","volume":"43","author":"Lee","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.bulcan.2023.08.002_bib0820","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/PAS.0000000000001543","article-title":"Uterine tumor resembling ovarian sex cord stromal tumor (UTROSCT): a series of 3 cases with extensive rhabdoid differentiation, malignant behavior, and ESR1-NCOA2 fusions","volume":"44","author":"Bennett","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.bulcan.2023.08.002_bib0825","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/PGP.0000000000000240","article-title":"Uterine tumor resembling ovarian sex cord tumor (UTROSCT) commonly exhibits positivity with sex cord markers FOXL2 and SF-1 but lacks FOXL2 and DICER1 mutations","volume":"35","author":"Croce","year":"2016","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"10.1016\/j.bulcan.2023.08.002_bib0830","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/PAS.0000000000000367","article-title":"FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors","volume":"39","author":"Chiang","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0835","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/gcc.22909","article-title":"An update of molecular findings in uterine tumor resembling ovarian sex cord tumor and GREB1-rearranged uterine sarcoma with variable sex-cord differentiation","volume":"60","author":"Kao","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.bulcan.2023.08.002_bib0840","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/gcc.22694","article-title":"GREB1-CTNNB1 fusion transcript detected by RNA-sequencing in a uterine tumor resembling ovarian sex cord tumor (UTROSCT): a novel CTNNB1 rearrangement","volume":"58","author":"Croce","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.002_bib0845","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/PAS.0000000000001153","article-title":"Uterine tumor resembling ovarian sex cord tumor: a distinct entity characterized by recurrent NCOA2\/3 gene fusions","volume":"43","author":"Dickson","year":"2019","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.08.002_bib0850","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/PAS.0000000000001348","article-title":"Uterine tumor resembling ovarian sex cord tumor (UTROSCT): a morphologic and molecular study of 26 cases confirms recurrent NCOA1-3 rearrangement","volume":"44","author":"Goebel","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0855","series-title":"Female genital tumours","article-title":"Inflammatory myofibroblastic tumours","author":"Parra-Herran","year":"2020"},{"issue":"2","key":"10.1016\/j.bulcan.2023.08.002_bib0860","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/PAS.0000000000000330","article-title":"Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course","volume":"39","author":"Parra-Herran","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.bulcan.2023.08.002_bib0865","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/modpathol.2017.69","article-title":"Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.bulcan.2023.08.002_bib0870","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/PAS.0000000000000909","article-title":"Inflammatory myofibroblastic tumors of the female genital tract are under-recognized: a low threshold for ALK immunohistochemistry is required","volume":"41","author":"Pickett","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0875","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.humpath.2020.09.005","article-title":"Inflammatory myofibroblastic tumors associated with the placenta: a series of 9 cases","volume":"106","author":"Makhdoum","year":"2020","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.bulcan.2023.08.002_bib0880","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/PAS.0000000000001481","article-title":"Pregnancy-associated inflammatory myofibroblastic tumors of the uterus are clinically distinct and highly enriched for TIMP3-ALK and THBS1-ALK fusions","volume":"44","author":"Devereaux","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.08.002_bib0885","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/PAS.0000000000001756","article-title":"Uterine inflammatory myofibroblastic neoplasms with aggressive behavior, including an epithelioid inflammatory myofibroblastic sarcoma: a clinicopathologic study of 9 cases","volume":"46","author":"Collins","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.bulcan.2023.08.002_bib0890","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/PAS.0b013e318200cfd5","article-title":"Epithelioid inflammatory myofibroblastic sarcoma: an aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK","volume":"35","author":"Marino-Enriquez","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.bulcan.2023.08.002_bib0895","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/gcc.22986","article-title":"Uterine inflammatory myofibroblastic tumor: first report of a ROS1 fusion","volume":"60","author":"Bennett","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0900","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humpath.2019.12.006","article-title":"Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion","volume":"97","author":"Cheek","year":"2020","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.bulcan.2023.08.002_bib0905","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/annonc\/mdr610","article-title":"Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions","volume":"23","author":"Ray-Coquard","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2023.08.002_bib0910","first-page":"A624","article-title":"Discordant diagnoses in sarcoma, GIST and desmoide tumour in France: results from the network RREPS","volume":"17","author":"Perrier","year":"2012","journal-title":"Value Health"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745512300348X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745512300348X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:38:45Z","timestamp":1757792325000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000745512300348X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S000745512300348X"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.08.002","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic des sarcomes ut\u00e9rins et tumeurs m\u00e9senchymateuses ut\u00e9rines rares \u00e0 potentiel de malignit\u00e9. R\u00e9f\u00e9rentiels du Groupe Sarcome Fran\u00e7ais et des Tumeurs Rares Gyn\u00e9cologiques","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2023.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}